Empagliflozin, soluble in DMSO and insoluble in ethanol and water, is a sodium-glucose cotransporter inhibitor, preventing the kidneys from reabsorbing glucose. It targets SGLT1, SGLT2, SGLT4, SGLT5, and SGLT6.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.